Cell & Gene Therapy Webinar – Integrated mRNA & circRNA-tLNP Platform Empowering In Vivo CAR-T Therapies 04-16-2026 / Lauren Lu, Sr. Director, Plasmid Business Dept., ProBio RNA therapeutics and targeted lipid nanoparticles (tLNP) are opening new possibilities for engineering CAR-T cells directly in the body. Learn More
Therapeutic Antibody Accelerating In Vivo CAR-T Antibody Discovery and Development | ProBio CDMO 04-09-2026 / Derek Chen, Sr. Director, Antibody Drug Discovery Dept., ProBio In vivo CAR-T therapy transforms T cells directly within the body, making treatment faster, simpler, and more accessible, with the potential for repeat dosing and targeting solid tumors. Antibodies guide CAR constructs to tumor-specific antigens, enabling Learn More
Cell & Gene Therapy In Vivo CAR T Made Real: Overcoming CMC Barriers 01-21-2026 / Jie Ma, Associate Director, Head of Product Marketing, ProBio Cell and gene therapies (CGT) are transforming disease treatment, with CAR-T therapies facing challenges like high costs and long production times. Learn More
Cell & Gene Therapy In Vivo CAR-T Webinar | Industrialization of In Vivo CAR-T Therapy Development | ProBio CDMO 12-02-2025 / Chunling Xuan, Director, LVV PD, ProBio;Jiang Xu Head of LNP formulation, ProBio; CAR-T therapies have revolutionized blood cancer treatment, but traditional ex vivo manufacturing remains costly and time-consuming. Next-generation in vivo CAR-T is set to change the game, driven by two delivery platforms: LVV (viral) and LNP...... Learn More
Therapeutic Antibody sdAb Discovery & ExpressCMC™ with Cell Line Development Webinar | ProBio CDMO 09-23-2025 / Derek Chen, Sr. Director, Antibody Drug Discovery Dept., ProBio...... sdAbs are unique type of antibodies derived from camelids and widely used as therapeutics, especially as building blocks for multi-specific antibodies. Learn More
Cell & Gene Therapy AAV Webinar | Design, Build & Scale AAV Discovery to Process Development | ProBio CDMO 08-26-2025 / Cheng Luo, Director of Pharmacology Dept., ProBio Adeno-associated viruses (AAVs) are widely used in gene therapy for its safety and ability to support long-term gene expression. Learn More
Therapeutic Antibody Biologics Webinar: From Lab Bench to GMP for BsAb & ADC | ProBio CDMO 07-31-2025 / Join us for an insightful seminar focused on the discovery and development of complex biologics, including bispecific antibodies (BsAbs) and antibody-drug conjugates (ADCs) Learn More
Therapeutic Antibody Bispecific Antibody Webinar | Advancing Challenging Biologics BsAb, ADC & RDC | ProBio CDMO 06-05-2025 / The BioForum ‘Advancing Challenging Biologics: BsAb, TsAb and RDC/ADC Innovations’, delivered by BioMelbourne Network in collaboration with ProBio, will discuss how the development of complex biologic therapies – including bi-specific and tri-specific ... Learn More